BADDIE
Health
powered by FELLA HEALTH
Do you have to keep GLP-1 in the fridge? Most GLP-1 receptor agonists require refrigeration when unopened, stored between 36°F and 46°F (2°C to 8°C) to maintain their effectiveness. These biologic medications contain temperature-sensitive protein molecules that can degrade if exposed to heat or freezing. Once opened, storage requirements vary by product—some multi-dose pens like Ozempic can remain at room temperature for up to 56 days, while others have shorter durations. Understanding proper storage for your specific medication is essential for ensuring therapeutic efficacy and preventing waste of these costly diabetes and weight management therapies.
Summary: Most unopened GLP-1 medications must be refrigerated at 36°F to 46°F (2°C to 8°C), but many can be stored at room temperature for limited periods once opened or in use.
Glucagon-like peptide-1 (GLP-1) receptor agonists are injectable medications used primarily for type 2 diabetes management and, in some formulations, for chronic weight management. These biologic medications contain protein-based molecules that are sensitive to temperature fluctuations, making proper storage essential for maintaining their therapeutic efficacy and safety profile.
Most injectable incretin medications require refrigeration between 36°F and 46°F (2°C to 8°C) when unopened. This temperature range preserves the structural integrity of the peptide molecule and prevents degradation that could reduce effectiveness or alter the medication's safety profile. The FDA-approved labels for semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), and tirzepatide (Mounjaro, Zepbound, a dual GIP/GLP-1 receptor agonist) all specify refrigeration as the primary storage method for unopened prefilled pens.
Once in use, storage requirements vary by specific product. Some medications may be kept at room temperature for a defined period, with durations ranging from 14 to 56 days depending on the formulation. Room temperature is generally defined as below 86°F (30°C), though some products specify a lower threshold of 77°F (25°C). It is critical to consult the specific product's FDA-approved Prescribing Information, Medication Guide, or Instructions for Use, as storage requirements differ between brands and even between different formulations of the same active ingredient.
Key storage principles include:
Never freeze these medications—freezing permanently damages the molecular structure
Protect pens from direct light and heat sources
Store in the original carton until ready for use
Keep away from the freezer compartment in refrigerators
Do not store in car glove compartments or other areas with temperature extremes
Note that oral semaglutide (Rybelsus) has different storage requirements than injectable products discussed in this article.
The storage requirements for GLP-1 and related injectable medications change significantly depending on whether the pen is unopened or in use. Understanding this distinction is essential for maintaining medication potency and preventing waste of these costly therapies.
Unopened pens must be stored in the refrigerator at 36°F to 46°F (2°C to 8°C) until the expiration date printed on the packaging. These should remain in their original carton to protect from light. Unopened medications should never be used past their expiration date, even if they have been continuously refrigerated.
Many products allow limited room temperature storage before first use:
Wegovy (semaglutide): up to 28 days at or below 86°F (30°C)
Mounjaro/Zepbound (tirzepatide): up to 21 days at or below 86°F (30°C)
Trulicity (dulaglutide): up to 14 days at or below 86°F (30°C)
If an unopened pen has been accidentally frozen, it must be discarded—there is no safe way to restore a frozen biologic medication.
For multi-dose pens after first use (in-use storage):
Ozempic (semaglutide): 56 days either refrigerated or at room temperature up to 86°F (30°C)
Victoza/Saxenda (liraglutide): 30 days either refrigerated or at room temperature up to 86°F (30°C)
For single-use pens (Trulicity, Mounjaro, Zepbound, Wegovy), the room temperature allowances apply before use only, as these pens are discarded immediately after the single dose is administered.
Always write the date of first use on multi-dose pen labels to track the allowable storage period. For products that can be stored either refrigerated or at room temperature after first use (like Ozempic and Victoza), returning the pen to the refrigerator after room temperature storage is permitted according to their FDA labels. Dispose of multi-dose pens after the specified number of days, even if medication remains—using expired in-use medication may result in reduced efficacy or unpredictable dosing.
Improper storage of GLP-1 and related medications can compromise their molecular structure, potentially reducing therapeutic effectiveness and raising safety concerns. These medications are peptide-based biologics, meaning they consist of chains of amino acids that maintain a specific three-dimensional structure essential for binding to their target receptors. Temperature extremes—both heat and freezing—can denature these proteins, altering their shape and function.
When these medications are exposed to temperatures above the recommended range, the peptide molecules may begin to degrade or aggregate. This process can occur gradually with prolonged exposure to moderately elevated temperatures or rapidly with exposure to high heat (such as in a hot car). Degraded medication may deliver a lower effective dose than intended, potentially resulting in inadequate glycemic control or reduced weight management efficacy. In clinical practice, patients who report diminished response to their usual dose should be asked about storage conditions as part of the assessment.
Freezing poses an even more immediate risk. When these solutions freeze, ice crystals form and physically disrupt the protein structure. This damage is irreversible—thawing a frozen pen does not restore the medication's integrity. Using a previously frozen medication may result in unpredictable absorption or reduced potency. The FDA labeling for all these products explicitly states that frozen medication must be discarded.
Signs that a medication may have been improperly stored include:
Visible particles, cloudiness, or discoloration in products labeled to be clear and colorless
Changes in viscosity or texture
Difficulty with injection or unusual resistance when using the pen
Note that some products, such as Bydureon BCise (extended-release exenatide), are suspensions rather than clear solutions, so appearance guidelines differ for these medications.
If you suspect your medication has been stored improperly, do not use it. Contact your pharmacist or healthcare provider for guidance. Most manufacturers offer patient support lines that can provide specific advice based on the storage conditions and duration of exposure.
Traveling with GLP-1 and related medications requires advance planning to maintain proper storage conditions while away from home. Whether traveling domestically or internationally, patients must balance the need for temperature control with practical considerations of portability and accessibility.
For air travel, these medications should always be carried in carry-on luggage, never checked baggage. Cargo holds can experience temperature extremes—both freezing at high altitudes and excessive heat on tarmacs—that will damage the medication. The Transportation Security Administration (TSA) permits passengers to carry injectable medications and associated supplies (including ice packs) through security checkpoints. According to TSA guidelines, medically necessary liquids, medications, and cooling accessories are exempt from the 3.4 oz liquid restriction. Patients should keep medications in their original labeled packaging and carry a copy of their prescription or a letter from their healthcare provider, particularly for international travel.
Maintaining appropriate temperature during travel:
Insulated medication travel cases or cooling pouches designed for injectable medications are recommended. These specialized cases often use gel packs or evaporative cooling technology to maintain temperatures below 86°F (30°C) for several hours, though many may not maintain full refrigeration temperatures (36°F-46°F). For unopened pens requiring refrigeration, consider using a thermometer to verify temperatures in travel containers. If using ice packs, ensure they do not come into direct contact with the medication pen—direct contact with frozen ice packs can freeze the medication. A barrier such as a small towel or the medication's original carton provides protection.
For hotel stays, request a room with a functioning refrigerator, or ask the front desk to store your medication in their refrigerator if in-room options are unavailable. When staying with friends or family, immediately place unopened pens in the refrigerator upon arrival.
For extended travel or destinations with limited refrigeration access, consult your healthcare provider in advance. For weekly medications (Ozempic, Wegovy, Trulicity, Mounjaro, Zepbound), maintain your dosing schedule based on the day of the week rather than attempting to adjust for time changes. For daily medications (Victoza, Saxenda), try to maintain a consistent 24-hour interval between doses when possible. Always ensure you have adequate supply plus extra in case of travel delays.
Despite clear labeling, several common storage errors can compromise GLP-1 and related medications. Recognizing and avoiding these mistakes helps ensure optimal therapeutic outcomes and prevents costly medication waste.
Storing pens in the refrigerator door: This is one of the most frequent errors. Refrigerator doors experience the greatest temperature fluctuations as they open and close throughout the day, and temperatures in door compartments often exceed the recommended range. Additionally, door storage increases the risk of the pen falling and being damaged. Instead, store medications on a middle or lower shelf toward the back of the refrigerator, away from the freezer compartment and any vents that might expose the medication to freezing temperatures.
Forgetting to track the in-use date: Many patients fail to record when they first use a multi-dose pen, making it impossible to know when the storage period expires. Use a permanent marker to write the date of first use directly on the pen label, or set a reminder on your phone for the disposal date. This simple step prevents the use of medication beyond its stability period.
Leaving medication in vehicles: Cars are particularly problematic storage locations. Even on mild days, interior temperatures can rise rapidly—reaching 100°F or higher within 30 minutes on a 70°F day. In winter, cars can drop below freezing overnight. Never leave these medications in a vehicle, even briefly. If you must transport medication, use an insulated case and take it with you when leaving the car.
Assuming all products have identical storage requirements: While these medications share similar storage principles, specific requirements vary by product. For example, the duration that multi-dose pens can remain at room temperature ranges from 30 to 56 days depending on the brand. Always verify the storage requirements for your specific medication rather than assuming they match a different product you may have used previously.
Not inspecting medication before use: Patients should visually inspect their medication before each injection. For products labeled as solutions, the liquid should be clear and colorless (or as specified in the product labeling). Note that suspension products like Bydureon BCise have different appearance expectations. Any unexpected appearance changes warrant discarding the pen and contacting your pharmacist.
Failing to plan for power outages: During extended power outages, keep the refrigerator door closed as much as possible to maintain temperature. For longer outages, transfer medications to a cooler with ice packs (ensuring no direct contact between ice and medication). If you are unsure whether your medication remained within the safe temperature range during an outage, contact your pharmacist or the medication manufacturer's patient support line for guidance before using it. If medication is compromised due to a power outage or natural disaster, contact your pharmacy and insurance company about replacement options, as coverage policies vary by insurer and state emergency provisions may apply.
Yes, many GLP-1 medications can be stored at room temperature after first use, but the duration varies by product. For example, Ozempic can remain at room temperature (up to 86°F) for 56 days after opening, while Victoza allows 30 days. Always check your specific product's FDA-approved labeling for exact storage requirements.
Discard any GLP-1 medication that has been frozen, as freezing permanently damages the protein structure and cannot be reversed by thawing. Using previously frozen medication may result in unpredictable absorption or reduced potency, and FDA labeling explicitly requires disposal of frozen products.
Always carry GLP-1 medications in your carry-on luggage, never in checked baggage where temperature extremes can damage them. Use an insulated medication travel case with gel packs (avoiding direct contact with ice), and keep medications in original labeled packaging. TSA permits medically necessary medications and cooling accessories through security checkpoints.
All medical content on this blog is created using reputable, evidence-based sources and is regularly reviewed for accuracy and relevance. While we strive to keep our content current with the latest research and clinical guidelines, it is intended for general informational purposes only.
This content is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a licensed healthcare provider with any medical questions or concerns. Use of this information is at your own risk, and we are not liable for any outcomes resulting from its use.
